There were 1,375 press releases posted in the last 24 hours and 427,133 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des patients adultes et pédiatriques atteints de NF1-PN

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image